EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer’s Disease

Yunfeng Li, Xiongjin Chen, Mulan Zhou, Sifan Feng, Xiaoping Peng, Yan Wang

Journal of Alzheimer's Disease · 02.01.2024 · 97 (1) · 75-88

DOI: 10.3233/jad-230273 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 02.01.2024. Verfasst von Yunfeng Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 104 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease is a pervasive neurodegenerative disease that is estimated to represent approximately 70% of dementia cases worldwide, and the molecular complexity that has been highlighted remains poorly understood. The accumulation of extracellular amyloid-β (Aβ), intracellular neurofibrillary tangles formed by tau hyperphosphorylation, and neuroinflammation are the major pathological features of Alzheimer’s disease (AD). Over the years, there has been no apparent breakthrough in drug discovery based on the Aβ and tau hypotheses. Neuroinflammation has gradually become a hot spot in AD treatment research. As the primary cells of innate immunity in the central nervous system, microglia play a key role in neuroinflammation. Toll-like receptor 4 (TLR4) and nucleotide-binding oligomerization domain-like receptor 3 (NLRP3) inflammasomes are vital molecules in neuroinflammation. In the pathological context of AD, the complex interplay between TLR4 and the NLRP3 inflammasomes in microglia influences AD pathology via neuroinflammation. In this review, the effect of the activation and inhibition of TLR4 and NLRP3 in microglia on AD pathology, as well as the cross-talk between TLR4 and the NLRP3 inflammasome, and the influence of essential molecules in the relevant signaling pathway on AD pathology, were expounded. In addition, the feasibility of these factors in representing a potential treatment option for AD has been clarified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesHumansInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinMicrogliaToll-Like Receptor 4Neuroinflammatory DiseasesAmyloid beta-PeptidesSignal Transduction

Stichwörter der Autor:innen

Alzheimer’s diseaseNLRP3 inflammasomesTLR4microglia

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinToll-Like Receptor 4Amyloid beta-PeptidesTLR4 protein, human

Autor:innen und Institutionen

  • Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Department of Pharmacy, The People's Hospital of Gaozhou, Maoming, China.

Zitieren

APA

Li, Y., Chen, X., Zhou, M., Feng, S., Peng, X., & Wang, Y. (2024). Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer’s Disease. Journal of Alzheimer's Disease, 97(1), 75-88. https://doi.org/10.3233/jad-230273

Vancouver

Li Y, Chen X, Zhou M, Feng S, Peng X, Wang Y. Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer’s Disease. Journal of Alzheimer's Disease. 2024;97(1):75-88. doi:10.3233/jad-230273

BibTeX
@article{Li2024,
  author = {Li, Yunfeng and Chen, Xiongjin and Zhou, Mulan and Feng, Sifan and Peng, Xiaoping and Wang, Yan},
  title = {Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer’s Disease},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  volume = {97},
  number = {1},
  pages = {75--88},
  doi = {10.3233/jad-230273}
}
Kostenlos starten →